Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV dementia: an evolving disease.

Justin C McArthur1

  • 1Johns Hopkins University HIV Neurosciences Program, Baltimore, MD, USA. jm@welchlink.welch.jhu.edu

Journal of Neuroimmunology
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Historical Case for a Strong and Diverse Neurology Clerkship Leadership Team.

Neurology. Education·2025
Same author

A 79-Year-Old Woman With Worsening Headaches and Pachymeningeal Enhancement: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.

Neurology(R) neuroimmunology & neuroinflammation·2024
Same author

Neurological Aspects of Substance Use Disorder: An Introduction.

Seminars in neurology·2024
Same author

Relapsing Anti-GAD65-Associated Encephalitis Responsive to Thymoma Resection, Radiation, and Immunomodulatory Therapy.

The Neurohospitalist·2024
Same author

Global neurology: It's time to take notice.

Annals of clinical and translational neurology·2023
Same author

Sheikh Khalifa Stroke Institute at Johns Hopkins: Transforming the Care of Patients With Stroke: Lessons Learned.

American journal of physical medicine & rehabilitation·2023

Highly active antiretroviral therapy (HAART) has improved HIV/AIDS survival and reduced dementia rates. However, neurological complications like HIV-associated dementia and sensory neuropathies persist, indicating HAART does not fully prevent neurological damage.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Advances in HIV care have improved prognosis for HIV+ individuals.
  • Understanding HIV replication's link to disease progression is crucial.
  • Highly active antiretroviral therapy (HAART) is widely available and effective in suppressing HIV.

Purpose of the Study:

  • To review outstanding questions regarding HIV-associated dementia (HIV-D).
  • To explore differing phenotypes and temporal patterns of HIV-D progression.
  • To investigate factors determining these temporal patterns and the impact of therapy on HIV-D.

Main Methods:

  • Review of existing literature on HIV-D and HAART.
  • Analysis of clinical data on the incidence and prevalence of neurological complications.

Related Experiment Videos

  • Examination of temporal progression patterns of HIV-D in patients on HAART.

    • Main Results:

    • HAART has significantly reduced opportunistic infections and HIV-D incidence by 40-50%.
    • Prevalence of sensory neuropathies in advanced HIV/AIDS exceeds 20% and may increase with neurotoxic HAART.
    • Combined prevalence of HIV-D and HIV-SN is 30-50%, suggesting incomplete neurological protection by HAART.

    Conclusions:

    • HAART has improved survival and altered the temporal progression of HIV-D, often resulting in attenuated forms.
    • Despite HAART's benefits, HIV-D and HIV-SN remain common neurological disorders associated with AIDS.
    • Further research is needed to understand the nuances of HIV-D phenotypes, progression, and the full impact of therapy.